This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
Bloomberg News
bloomberg.com
did:plc:uewxgchsjy4kmtu7dcxa77us
Under new drug-review rules, decisions at the FDA risk becoming more opaque, arbitrary or even politically motivated—making it far harder for pharma companies and their investors to model and plan.
https://bloom.bg/4qmehq5
2026-02-09T15:30:16.155Z